Association Between American Society of Anesthesiologists Physical Status Classification System and Remimazolam Sedation Outcomes
Academic Emergency Medicine · 2026-04 · 33 (4)
DOI: 10.1111/acem.70306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Emergency Medicine, online erschienen am 27.04.2026. Verfasst von Caroline H Brynning und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine and Trauma Center, EMRUn, Aalborg University Hospital, Aalborg, Denmark. Hauptthemen laut MEDLINE: Hypnotics and Sedatives, Benzodiazepines, Procedural Sedation. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Remimazolam (RM) is an ultrashort‐acting benzodiazepine with pharmacodynamic properties ideal for procedural sedation in emergency departments (EDs). This study evaluated the safety of RM when used for procedural sedation of American Society of Anesthesiologists (ASA) I–III patients in the ED.
Aims
To compare the occurrence of no or mild/moderate respiratory complications during procedural sedation in patients with ASA scores I, II, and III. Secondarily, to compare clinical characteristics of RM sedations between the ASA groups.
Methods
This qualitative improvement study was conducted in 2024 and 2025 at a Danish Level 1 trauma center. RM was administered to ASA I–III patients ≥ 12 years of age as procedural sedation by emergency medicine physicians or nurses educated in airway management, RM sedation, and adverse events. Safety was measured by the occurrence of respiratory problems graded as none, mild, moderate, or severe.
Results
Of the 540 patients sedated with RM, 95%–100% in ASA I–III had no or mild/moderate respiratory complications, with ASA I and III being the safest groups ( p < 0.014). ASA III patients had the most potential airway risks, but still experienced fewer severe respiratory complications than ASA II patients (4.7% vs. 1.3%, p = 0.014). The RM dose was found to be age‐, gender‐ and ASA score‐dependent.
Conclusions
RM showed great potential for procedural sedation and was safe for procedural sedation of ASA I–III patients in the ED, with few serious respiratory complications, even in high doses and with high‐risk profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine and Trauma Center, EMRUn, Aalborg University Hospital, Aalborg, Denmark.
- Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
ORCID-Profile: Caroline H Brynning, Simone P Busch, Anne L Krarup, Dorte Melgaard
Zitieren
APA
Brynning, C. H., Busch, S. P., Krarup, A. L., & Melgaard, D. (2026). Association Between American Society of Anesthesiologists Physical Status Classification System and Remimazolam Sedation Outcomes. Academic Emergency Medicine, 33(4). https://doi.org/10.1111/acem.70306
Vancouver
Brynning CH, Busch SP, Krarup AL, Melgaard D. Association Between American Society of Anesthesiologists Physical Status Classification System and Remimazolam Sedation Outcomes. Academic Emergency Medicine. 2026;33(4). doi:10.1111/acem.70306
BibTeX
@article{Brynning2026,
author = {Brynning, Caroline H and Busch, Simone P and Krarup, Anne L and Melgaard, Dorte},
title = {Association Between American Society of Anesthesiologists Physical Status Classification System and Remimazolam Sedation Outcomes},
journal = {Academic Emergency Medicine},
year = {2026},
volume = {33},
number = {4},
doi = {10.1111/acem.70306}
}
EUVIMED